Daibao STC High-Speed Tubular Centrifuge for Biopharmaceutical Separation

Daibao Machinery Equipment Co., Ltd. is a leading Chinese high-tech enterprise specializing in the research, development, and manufacturing of tubular centrifuges. In 2013, the company acquired core tubular centrifuge technology from the Shanghai Centrifugal Machinery Research Institute, building on decades of technical heritage. This foundation has enabled Daibao to develop high-speed and fully automatic tubular centrifuges that filled a critical industry gap, ending China’s 30-year reliance on manual discharge processes.

Today, Daibao serves over 600 clients worldwide, including more than 200 biopharmaceutical companies such as Harbin Pharmaceutical Group, Tongrentang, Yunnan Baiyao, and Hengrui Medicine—among them over 20 publicly listed enterprises. The STC series represents the pinnacle of this innovation, offering a high-capacity rotor (φ140mm × 760mm) that reaches speeds up to 14,000 rpm and a separation factor of 15,366 ×g, ensuring reliable handling of demanding separations.

In biopharmaceutical manufacturing, achieving efficient and sterile separation has long been a critical challenge. The STC series of fully automatic tubular centrifuges redefines separation processes with advanced automation and exceptional performance. Designed for key applications such as cell harvest, fermentation broth clarification, and biotherapeutic purification, it features full-process automation with “one-button start/stop” enabling unattended operation that meets stringent GMP standards.

Daibao’s tubular centrifuges are not only ideal for biopharmaceutical use but also excel in chemical, food, and environmental industries. The combination of high-speed separation, automatic operation, and robust construction makes the STC series a cost-effective solution for improving productivity and product quality. With a global reputation and continuous technical support, Daibao ensures that every centrifuge delivers optimal performance and long-term reliability.